Xavier Jacq is the Chief Scientific Officer at MitoRx Therapeutics, leveraging extensive expertise in drug discovery, biochemistry, and molecular biology. His distinguished background includes a Ph. D. from Université Louis Pasteur, postdoctoral research at Columbia University, and multiple scientific leadership and advisory roles across the industry.
He is keenly interested in developing novel therapeutics for metabolic diseases, particularly obesity, and frequently presents new findings at major international conferences. His work also extends to AI applications in the pharmaceutical industry through his board-level involvement.
He is a co-inventor on multiple patents for novel inhibitors of cysteine proteases, designed specifically for therapeutic applications in oncology.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.